Souhrn s komentářem. Citace: Williams R, de Vries F., Kothny W, et al.
Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study. Diabetes Obes Metab. 2017 Oct;19(10): 1473-1478.